Example: Heart Attack

Clinical Trials on Immunoglobulin Light-chain Amyloidosis

Total 4 results

NCT04659798

Recruiting

A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice

Conditions: Multiple Myeloma, Immunoglobulin Light-chain Amyloidosis
NCT04612582

Recruiting

Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis

Conditions: Immunoglobulin Light-Chain Amyloidosis
NCT01383759

Completed

Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis

Conditions: Light Chain Deposition Disease (LCDD or MIDD), Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD), Monoclonal Immunoglobulin Deposition Disease (MIDD), Amyloidosis
NCT03130348

Withdrawn

Ibrutinib With or Without Bortezomib and Dexamethasone in Treating Patients With Relapsed or Refractory Immunoglobulin Light Chain Amyloidosis

Conditions: Amyloidosis, Immunoglobulin Light Chain Deposition